Blueprint Medicines (BPMC): next trial readout expected around 2026-12-31
$BPMC · Blueprint Medicines CorporationTrials that could report in the next 12 months: 4BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything BPMC is running — see methodology.
- 2026-12-31in 19wStudy of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
- 2027-06-23in 44w(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
- 2027-12-31in 71wAvapritinib Rollover Study
- 2032-09-30in 319w(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Place… | Phase 2 | Recruitingstill enrolling patients | 2032-09-30 | NCT04910685 |
| Avapritinib Rollover Study | Phase 4 | Recruitingstill enrolling patients | 2027-12-31 | NCT06748001 |
| (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-28… | Phase 2 | Active Not Recruitingenrolled, still running | 2027-06-23 | NCT03731260 |
| Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Sp… | Phase 2 | Active Not Recruitingenrolled, still running | 2026-12-31 | NCT06931405 |
| A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors… | Phase 1 | Recruitingstill enrolling patients | NCT07629960 |
Status-change history
Every ClinicalTrials.gov change recorded for BPMC's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is BPMC's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is BPMC's lead program in?
Phase 2 — active not recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.